Originalpublikationen
Arnold MB, ...Riemekasten G, et al. Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis. Rheumatology (Oxford). 2018 Jan 1;57(1):152-157.doi: 10.1093/rheumatology/kex396
Herrick AL, ..., Riemekasten G, et al. Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study. Ann Rheum Dis. 2018 Apr;77(4):563-570. doi:10.1136/annrheumdis-2017-211912
Adler S, ...Riemekasten G; EUSTAR co-workers on behalf of the DeSScipher project research group within the EUSTAR network.Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group. Arthritis Res Ther. 2018 Jan 30;20(1):17. doi: 10.1186/s13075-018-1517-z.
Peytrignet S, ... Riemekasten G, et al. Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study. Rheumatology (Oxford). 2018 Feb 1;57(2):370-381. doi: 10.1093/rheumatology/kex410
Recke A, Regensburger AK, Weigold F, Müller A, Heidecke H, Marschner G, Hammers CM, Ludwig RJ, Riemekasten G. Autoantibodies in Serum of Systemic Scleroderma Patients: Peptide-Based Epitope Mapping
Indicates Increased Binding to Cytoplasmic Domains of CXCR3. Front Immunol. 2018 Mar 22;9:428. doi: 10.3389/fimmu.2018.00428. eCollection 2018
Weigold F, ... Riemekasten G. Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis. Arthritis Res Ther. 2018 Mar 22;20(1):52. doi: 10.1186/s13075-018-1545-8.
Preis E, ... Riemekasten G, et al. The impact of malnutrition on quality of life in patients with systemic sclerosis. Eur J Clin Nutr. 2018 Apr;72(4):504-510. doi: 10.1038/s41430-018-0116-z. Epub 2018 Mar 8.
Siegert E, ... Riemekasten G, et al. Prevalence of sarcopenia in systemic sclerosis: assessing body composition and functional disability in patients with systemic sclerosis. Nutrition. 2018 Nov;55-56:51-55. doi: 10.1016/j.nut.2018.03.046. Epub 2018 Apr 3
Kerstein A, Müller A, Pitann S, Riemekasten G, Lamprecht P. Circulating CD4+CD8+ double-positive T-cells display features of innate and adaptive immune function in granulomatosis with polyangiitis. Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):93-98. Epub 2018 May 18
Issac JM, ... Riemekasten G, et al. Induction of Hypergammaglobulinemia and Autoantibodies by Salmonella Infection in MyD88-Deficient Mice. Front Immunol. 2018 Jun 20;9:1384. doi: 10.3389/fimmu.2018.01384. eCollection 2018.
Weppner G, Ohlei O, Hammers CM, Holl-Ulrich K, Voswinkel J, Bischof J, Hasselbacher K, Riemekasten G, Lamprecht P, Ibrahim S, Iking-Konert C, Recke A, Müller A. In situ detection of PR3-ANCA+ B cells and alterations in the variable region of immunoglobulin genes support a role of inflamed tissue in the emergence of auto-reactivity in granulomatosis with polyangiitis. J Autoimmun. 2018 Sep;93:89-103. doi: 10.1016/j.jaut.2018.07.004. Epub 2018 Jul 24
Carreira PE, ... Riemekasten G, et al. and the EUSTAR co-authors. Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database. Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):68-75. Epub 2018 Sep 29.0
Ernst D, ... Riemekasten G. Beta-1-Adrenergic Receptor Antibodies in Acute Coronary Syndrome: Is Less Sometimes More? Front Cardiovasc Med. 2018 Nov 22;5:170. doi: 10.3389/fcvm.2018.00170. eCollection 2018
Rothe M, Rommel F, Klapa S, Humrich JY, Nieberding R, Lange T, Sochurek JAM, Plöttner P, Grisanti S, Riemekasten G, Ranjbar M. Evaluation of retinal microvascular perfusion in systemic sclerosis: a case-control study. Ann Rheum Dis. 2019 Jan 3. pii: annrheumdis-2018-214541. doi: 10.1136/annrheumdis-2018-214541.
Wang K, ... Riemekasten G, et al. CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease. Rheumatology (Oxford). 2018 Dec 22. doi: 10.1093/rheumatology/key425.
Cabral-Marques O, Marques A, Giil LM, De Vito R, Rademacher J, Günther J, Lange T, Humrich JY, Klapa S, Schinke S, Schimke LF, Marschner G, Pitann S, Adler S, Dechend R, Müller DN, Braicu I, Sehouli J, Schulze-Forster K, Trippel T, Scheibenbogen C, Staff A, Mertens PR, Löbel M, Mastroianni J, Plattfaut C, Gieseler F, Dragun D, Engelhardt BE, Fernandez-Cabezudo MJ, Ochs HD, Al-Ramadi BK, Lamprecht P, Mueller A, Heidecke H, Riemekasten G. GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis. Nat Commun. 2018 Dec 6;9(1):5224. doi: 10.1038/s41467-018-07598-9.
Giil LM, ... Riemekasten G, et al. Antibodies to Multiple Receptors are Associated with Neuropsychiatric Symptoms and Mortality in Alzheimer's Disease: A Longitudinal Study. J Alzheimers Dis. 2018;64(3):761-774. doi: 10.3233/JAD-170882.
Lamprecht P, Fischer N, Huang J, Burkhardt L, Lütgehetmann M, Arndt F, Rolfs I, Kerstein A, Iking-Konert C, Laudien M. Changes in the composition of the upper respiratory tract microbial community in granulomatosis with polyangiitis. J Autoimmun. 2019 Feb;97:29-39. doi: 10.1016/j.jaut.2018.10.005. Epub 2018 Nov 9
Reviews, Letters, Reports, etc.
Lamprecht P, Humrich JY, Diebold I, Riemekasten G. Diagnosis of deficiency of adenosine deaminase 2 with early onset polyarteritis nodosa in an adult patient with a novel compound heterozygous CECR1 mutation. Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):177. Epub 2018 Mar 15.
Lamprecht P, Kerstein A, Klapa S, Schinke S, Karsten CM, Yu X, Ehlers M, Epplen JT, Holl-Ulrich K, Wiech T, Kalies K, Lange T, Laudien M, Laskay T, Gemoll T, Schumacher U, Ullrich S, Busch H, Ibrahim S, Fischer N, Hasselbacher K, Pries R, Petersen F, Weppner G, Manz R, Humrich JY, Nieberding R, Riemekasten G, Müller A. Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides. Front Immunol. 2018 Apr 9;9:680. doi: 10.3389/fimmu.2018.00680. eCollection 2018.
Özden F, Schinke S, Thorns C, Eckey T, Dalhoff K, Münte TF, Tronnier V, Humrich JY, Riemekasten G, Lamprecht P. Detection of anti-neutrophil cytoplasmic and antinuclear autoantibodies favouring misdiagnoses in 5 cases of Erdheim-Chester disease. Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):176. Epub 2018 Apr 10.
Yu X, Riemekasten G, Petersen F. Autoantibodies against muscarinic acetylcholine receptor M3 in Sjogren's syndrome and corresponding mouse models. Front Biosci (Landmark Ed). 2018 Jun 1;23:2053-2064.
Leuchte HH, ... Riemekasten G, et al. Risk stratification strategy and assessment of disease progression in patients with pulmonary arterial hypertension: Updated Recommendations from the Cologne Consensus Conference 2018. Int J Cardiol. 2018 Dec 1;272S:20-29. doi: .1016/j.ijcard.2018.08.084. Epub 2018 Sep 13
Gabay C, ... Lamprecht P, et al. Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease. Ann Rheum Dis. 2018 Jun;77(6):840-847. doi: 10.1136/annrheumdis-2017-212608. Epub 2018 Feb 22.
Konferenzbeiträge
